Winter of discontent

As the NHS remains in intensive care, its long-term future is shrouded in doubt
NHS: Back to the future

We must look after an entire nation’s health – regardless of wealth
Pause for thought

Pharmacy’s central role in women’s health – including the menopause – must reflect a more modern, tailored approach
Love hearts

How can we use precision medicine to improve heart failure care?

News

View all

2023 PM Society Awards – Winners Announced

21GRAMS takes four Golds plus Best in Show AstraZeneca tops the pharma leader board

24th March 2023

Destiny releases pivotal phase 2 data involving XF-73 nasal gel

Study shows significant reduction of nasal S. aureus in cardiac surgery patients before surgery

24th March 2023

Debiopharm reveals phase 1/2 GaLuCi research results

The multi-centre international clinical trial will evaluate company’s Debio 0328 candidate

24th March 2023

Ono and Macomics join forces to develop cancer therapy

The partnership will involve progressing macrophage-targeting antibody treatment for cancer

23rd March 2023

Recommendation from NICE for PTC Therapeutics gene therapy

Eladocagene exuparvovec is for children with ultra-rare genetic disorder in final draft guidance

23rd March 2023

Magazine

View more from the latest edition

We all stand together

PharmaTimes’ Editor John Pinching talks to AstraZeneca’s inspiring diversity and inclusion leader for Europe and Canada, Anna-Lena Engwall

A nation prescribed

England’s prescribing trends provide a host of intriguing insights

Everything I own?

Digging deep into the maelstrom of intellectual property in pharma

Challenge of our age

Data quality governance – dispelling five common myths

Love hearts

How can we use precision medicine to improve heart failure care?

NHS: Back to the future

We must look after an entire nation’s health – regardless of wealth

Pause for thought

Pharmacy’s central role in women’s health – including the menopause – must reflect a more modern, tailored approach

Winter of discontent

As the NHS remains in intensive care, its long-term future is shrouded in doubt

Thought Leadership

View all

The time is now: Taking action for a sustainable supply chain

Leading pharma companies are setting targets for reducing their greenhouse gas emissions, and reporting on their progress in meeting them. That’s according to a new study we at Oxford PharmaGenesis conducted in collaboration with researchers from the University of Oxford. But when it comes to reporting on supply chain emissions, more collaboration is needed – and the time is now.

How can pharma and med device companies support the NHS with service optimisation?

The NHS faces many challenges when it comes to service efficiencies

Empowering health innovation: Birmingham boosting lab capacity

Professor Gino Martini, CEO of the Precision Health Technologies Accelerator (PHTA Ltd), explains how Birmingham is providing the collaborative space to simultaneously drive innovation in pharma, and tackle health inequality.

Is the SmPC still relevant in the digital age?

Post-pandemic, we have been forced to rethink the way in which medicines information is disseminated and consumed.

Webinars

View all

Diversity in Pharma: The Impact of COVID-19 on DE&I

Thursday, 23 June 2022 - 3:00 pm

COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative.

Andrés López Castaño, Tricia Lucas-Clarke, Noor Shaker, Sandra Van de Cauter, Marsha N. Ganthier

FREE | REGISTER NOW

Patient Perspectives to Improve Retention with eConsent

Tuesday, 22 February 2022 - 4:00 pm

With Tufts reporting that the average number of patient dropouts for clinical trials remains near 30%, it is clear that there is still much to be done towards improving retention¹.

Andrew Mackinnon, Digital Trial Operations Lead, Medable

FREE | ATTEND

Focusing on Patient-centricity for the Future of Pharma

Wednesday, 21 July 2021 - 2:00 pm

In healthcare, the patient voice is arguably the most important. Services and care work best when a person’s needs are fully met and they feel heard, respected and valued.

Mark Doyle, co-founder of The Method and creator of A Life in a Day

FREE | ATTEND